Aptose Biosciences Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Note 7 - Investments (Tables)

Note 7 - Investments (Tables)

12 Months Ended

Dec. 31, 2020

Notes Tables

Investment [Table Text Block]

			December 31, 2020
			Cost				Unrealized gain/(loss)				Market value

United States Treasury Bills			5,000				-				5,000
			5,000				-				5,000

			December 31, 2019
			Cost				Unrealized gain				Market value

Guaranteed investment certificates, issued by a Canadian financial institution			12,008				18				12,026
Commercial notes			3,736				-				3,736
Canadian provincial promissory note			1,996				-				1,996
			17,740				18				17,758